Walter Wai-Yip Chan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastroesophageal Reflux | 31 | 2024 | 816 | 10.010 |
Why?
|
Esophageal pH Monitoring | 27 | 2024 | 201 | 4.650 |
Why?
|
Eosinophilic Esophagitis | 9 | 2024 | 192 | 4.430 |
Why?
|
Esophageal Motility Disorders | 7 | 2023 | 48 | 4.400 |
Why?
|
Lung Transplantation | 14 | 2024 | 1305 | 4.180 |
Why?
|
Esophagitis, Peptic | 7 | 2023 | 76 | 3.680 |
Why?
|
Proton Pump Inhibitors | 15 | 2024 | 530 | 3.450 |
Why?
|
Idiopathic Pulmonary Fibrosis | 6 | 2023 | 500 | 2.450 |
Why?
|
Manometry | 18 | 2024 | 453 | 2.360 |
Why?
|
Esophagus | 7 | 2024 | 1023 | 2.330 |
Why?
|
Electric Impedance | 22 | 2023 | 754 | 2.270 |
Why?
|
Gastritis | 4 | 2024 | 199 | 2.160 |
Why?
|
Gastrointestinal Diseases | 5 | 2022 | 1184 | 2.030 |
Why?
|
Deglutition Disorders | 6 | 2023 | 626 | 2.030 |
Why?
|
Enteritis | 2 | 2024 | 162 | 1.660 |
Why?
|
Gastroenterology | 5 | 2023 | 571 | 1.640 |
Why?
|
Defecation | 2 | 2024 | 190 | 1.520 |
Why?
|
Eosinophilia | 2 | 2024 | 559 | 1.300 |
Why?
|
Irritable Bowel Syndrome | 2 | 2022 | 453 | 1.110 |
Why?
|
Pharynx | 5 | 2022 | 432 | 1.080 |
Why?
|
Graft Rejection | 5 | 2024 | 4426 | 1.020 |
Why?
|
Colonoscopy | 6 | 2024 | 1385 | 1.010 |
Why?
|
Lung Diseases | 3 | 2021 | 1908 | 1.000 |
Why?
|
Hydrogen-Ion Concentration | 10 | 2023 | 2497 | 0.940 |
Why?
|
Heartburn | 3 | 2023 | 68 | 0.930 |
Why?
|
Anal Canal | 2 | 2024 | 373 | 0.900 |
Why?
|
Cough | 5 | 2024 | 594 | 0.890 |
Why?
|
Rifamycins | 1 | 2022 | 26 | 0.840 |
Why?
|
Esophageal Achalasia | 1 | 2023 | 94 | 0.830 |
Why?
|
Gastric Emptying | 2 | 2024 | 242 | 0.830 |
Why?
|
Retrospective Studies | 41 | 2024 | 79982 | 0.790 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 362 | 0.760 |
Why?
|
Fecal Incontinence | 1 | 2024 | 241 | 0.760 |
Why?
|
Larynx | 2 | 2023 | 492 | 0.760 |
Why?
|
Endoscopy, Digestive System | 4 | 2024 | 351 | 0.750 |
Why?
|
Swallows | 1 | 2020 | 4 | 0.740 |
Why?
|
Hernia, Hiatal | 1 | 2021 | 90 | 0.700 |
Why?
|
Bulimia Nervosa | 1 | 2022 | 206 | 0.690 |
Why?
|
Dyspepsia | 2 | 2023 | 116 | 0.680 |
Why?
|
Bronchiolitis Obliterans | 1 | 2020 | 213 | 0.630 |
Why?
|
Lipase | 1 | 2020 | 324 | 0.600 |
Why?
|
Humans | 104 | 2024 | 757650 | 0.600 |
Why?
|
Middle Aged | 50 | 2024 | 219219 | 0.580 |
Why?
|
Helicobacter Infections | 2 | 2023 | 385 | 0.570 |
Why?
|
Muscle Contraction | 1 | 2021 | 1196 | 0.550 |
Why?
|
Drug Administration Schedule | 2 | 2024 | 4845 | 0.540 |
Why?
|
Cecum | 1 | 2017 | 233 | 0.540 |
Why?
|
Eosinophils | 2 | 2024 | 947 | 0.540 |
Why?
|
Adult | 42 | 2024 | 219747 | 0.530 |
Why?
|
Esophageal Sphincter, Upper | 1 | 2016 | 11 | 0.530 |
Why?
|
Male | 58 | 2024 | 358227 | 0.530 |
Why?
|
Deglutition | 2 | 2016 | 208 | 0.520 |
Why?
|
Deep Sedation | 1 | 2017 | 118 | 0.520 |
Why?
|
Clostridium Infections | 2 | 2019 | 557 | 0.510 |
Why?
|
Esophagoscopy | 4 | 2020 | 390 | 0.500 |
Why?
|
Female | 58 | 2024 | 389985 | 0.500 |
Why?
|
Proportional Hazards Models | 5 | 2024 | 12400 | 0.490 |
Why?
|
Esophageal Stenosis | 1 | 2016 | 192 | 0.480 |
Why?
|
Constipation | 4 | 2024 | 561 | 0.480 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2024 | 866 | 0.470 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3077 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3197 | 0.460 |
Why?
|
Intestine, Small | 2 | 2017 | 1205 | 0.450 |
Why?
|
Abdominal Pain | 2 | 2020 | 1064 | 0.450 |
Why?
|
Pancreatitis | 1 | 2020 | 1096 | 0.430 |
Why?
|
Liver Cirrhosis | 2 | 2020 | 1931 | 0.430 |
Why?
|
Bronchoconstriction | 1 | 2013 | 139 | 0.420 |
Why?
|
Appointments and Schedules | 1 | 2016 | 441 | 0.420 |
Why?
|
Superinfection | 1 | 2012 | 63 | 0.420 |
Why?
|
Esophageal Diseases | 1 | 2013 | 168 | 0.410 |
Why?
|
Recurrence | 2 | 2024 | 8426 | 0.410 |
Why?
|
Catheter Ablation | 1 | 2024 | 2741 | 0.360 |
Why?
|
Lung Injury | 1 | 2015 | 424 | 0.360 |
Why?
|
Proteomics | 1 | 2024 | 3816 | 0.360 |
Why?
|
Aged | 27 | 2024 | 167889 | 0.360 |
Why?
|
Fundoplication | 1 | 2011 | 144 | 0.350 |
Why?
|
Ambulatory Care | 1 | 2021 | 2767 | 0.350 |
Why?
|
Tissue Donors | 1 | 2019 | 2311 | 0.340 |
Why?
|
Gastroparesis | 2 | 2022 | 136 | 0.340 |
Why?
|
Monitoring, Ambulatory | 2 | 2023 | 352 | 0.340 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3762 | 0.340 |
Why?
|
Breath Tests | 2 | 2022 | 297 | 0.340 |
Why?
|
Gastric Bypass | 4 | 2019 | 817 | 0.340 |
Why?
|
Cost-Benefit Analysis | 6 | 2023 | 5481 | 0.320 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 623 | 0.320 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2523 | 0.310 |
Why?
|
Risk Factors | 15 | 2024 | 73716 | 0.300 |
Why?
|
Rectum | 2 | 2024 | 891 | 0.300 |
Why?
|
Esophagogastric Junction | 2 | 2021 | 341 | 0.290 |
Why?
|
Critical Illness | 1 | 2020 | 2704 | 0.290 |
Why?
|
Cohort Studies | 11 | 2020 | 41198 | 0.280 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2141 | 0.270 |
Why?
|
Patient Compliance | 1 | 2016 | 2685 | 0.270 |
Why?
|
Preoperative Care | 2 | 2014 | 2246 | 0.260 |
Why?
|
Hospitals | 1 | 2019 | 3861 | 0.260 |
Why?
|
Laxatives | 2 | 2023 | 92 | 0.260 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1230 | 0.260 |
Why?
|
Kaplan-Meier Estimate | 4 | 2024 | 6469 | 0.250 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3319 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2016 | 2212 | 0.250 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5105 | 0.250 |
Why?
|
Hypopharynx | 2 | 2021 | 53 | 0.240 |
Why?
|
Diarrhea | 2 | 2022 | 1317 | 0.240 |
Why?
|
Bacterial Infections | 1 | 2012 | 1401 | 0.240 |
Why?
|
Quality of Life | 2 | 2023 | 13265 | 0.230 |
Why?
|
Prevalence | 4 | 2024 | 15641 | 0.230 |
Why?
|
Telemedicine | 1 | 2021 | 3016 | 0.220 |
Why?
|
United States | 11 | 2024 | 71907 | 0.220 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5382 | 0.220 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12047 | 0.220 |
Why?
|
Omeprazole | 1 | 2024 | 105 | 0.220 |
Why?
|
Asthma | 2 | 2013 | 6172 | 0.220 |
Why?
|
ROC Curve | 4 | 2024 | 3562 | 0.210 |
Why?
|
Reproductive Behavior | 1 | 2022 | 27 | 0.210 |
Why?
|
Preoperative Period | 2 | 2016 | 549 | 0.210 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2022 | 2417 | 0.210 |
Why?
|
Gallium | 1 | 2022 | 27 | 0.200 |
Why?
|
Hydrogen | 1 | 2022 | 171 | 0.200 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58559 | 0.200 |
Why?
|
Patient Readmission | 1 | 2015 | 3241 | 0.190 |
Why?
|
Silicones | 1 | 2022 | 227 | 0.190 |
Why?
|
Chronic Disease | 4 | 2024 | 9265 | 0.190 |
Why?
|
Chicago | 1 | 2021 | 254 | 0.180 |
Why?
|
Hyperbilirubinemia | 1 | 2020 | 74 | 0.180 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3217 | 0.180 |
Why?
|
Remission Induction | 2 | 2024 | 2391 | 0.180 |
Why?
|
Nausea | 2 | 2020 | 679 | 0.170 |
Why?
|
Case-Control Studies | 4 | 2023 | 22024 | 0.170 |
Why?
|
Anorexia | 1 | 2020 | 154 | 0.170 |
Why?
|
Journal Impact Factor | 1 | 2021 | 153 | 0.170 |
Why?
|
Vomiting | 2 | 2020 | 652 | 0.170 |
Why?
|
Massachusetts | 3 | 2021 | 8815 | 0.170 |
Why?
|
Helicobacter pylori | 1 | 2023 | 376 | 0.170 |
Why?
|
Lactulose | 1 | 2019 | 31 | 0.160 |
Why?
|
Ataxia | 1 | 2021 | 306 | 0.160 |
Why?
|
Communication Barriers | 1 | 2022 | 413 | 0.160 |
Why?
|
Laparoscopy | 1 | 2011 | 2032 | 0.160 |
Why?
|
Prospective Studies | 8 | 2024 | 54108 | 0.160 |
Why?
|
Videoconferencing | 1 | 2021 | 203 | 0.160 |
Why?
|
Colonic Polyps | 1 | 2024 | 550 | 0.160 |
Why?
|
Young Adult | 9 | 2024 | 58764 | 0.160 |
Why?
|
Hospitalists | 1 | 2022 | 294 | 0.160 |
Why?
|
Benchmarking | 2 | 2022 | 1042 | 0.160 |
Why?
|
Treatment Outcome | 11 | 2024 | 64242 | 0.150 |
Why?
|
Gastrointestinal Transit | 1 | 2019 | 99 | 0.150 |
Why?
|
Lung | 3 | 2023 | 9979 | 0.150 |
Why?
|
HIV Protease Inhibitors | 1 | 2020 | 432 | 0.150 |
Why?
|
Hospitalization | 4 | 2021 | 10633 | 0.150 |
Why?
|
Marijuana Abuse | 1 | 2022 | 410 | 0.150 |
Why?
|
Pandemics | 4 | 2022 | 8601 | 0.150 |
Why?
|
Telephone | 1 | 2021 | 625 | 0.150 |
Why?
|
Obesity | 3 | 2024 | 12869 | 0.140 |
Why?
|
Publications | 1 | 2019 | 194 | 0.140 |
Why?
|
Gastric Fistula | 1 | 2017 | 73 | 0.140 |
Why?
|
Consensus | 2 | 2024 | 3098 | 0.140 |
Why?
|
Hydrostatic Pressure | 1 | 2017 | 95 | 0.140 |
Why?
|
Acute Lung Injury | 1 | 2020 | 367 | 0.140 |
Why?
|
Office Visits | 1 | 2021 | 594 | 0.140 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1716 | 0.140 |
Why?
|
Risk Assessment | 4 | 2021 | 23819 | 0.140 |
Why?
|
Capsules | 1 | 2016 | 191 | 0.130 |
Why?
|
Perioperative Care | 1 | 2024 | 1024 | 0.130 |
Why?
|
Allergens | 1 | 2024 | 1402 | 0.130 |
Why?
|
Electrodes | 1 | 2018 | 614 | 0.130 |
Why?
|
Fluoroscopy | 2 | 2020 | 944 | 0.130 |
Why?
|
Intubation, Gastrointestinal | 1 | 2017 | 166 | 0.130 |
Why?
|
Endosonography | 2 | 2017 | 607 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 436 | 0.130 |
Why?
|
Logistic Models | 3 | 2020 | 13222 | 0.130 |
Why?
|
Health Care Surveys | 1 | 2023 | 2426 | 0.130 |
Why?
|
Midazolam | 1 | 2017 | 266 | 0.130 |
Why?
|
Ulcer | 1 | 2016 | 204 | 0.120 |
Why?
|
Granuloma | 1 | 2017 | 327 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1590 | 0.120 |
Why?
|
Intestinal Diseases | 1 | 2019 | 503 | 0.120 |
Why?
|
Adiposity | 1 | 2024 | 1858 | 0.110 |
Why?
|
Fiber Optic Technology | 1 | 2016 | 289 | 0.110 |
Why?
|
Reoperation | 1 | 2024 | 4279 | 0.110 |
Why?
|
Cathartics | 1 | 2014 | 127 | 0.110 |
Why?
|
Hoarseness | 1 | 2013 | 62 | 0.110 |
Why?
|
Odds Ratio | 2 | 2023 | 9624 | 0.110 |
Why?
|
Drug Costs | 1 | 2021 | 1179 | 0.110 |
Why?
|
Needles | 1 | 2016 | 450 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2017 | 1568 | 0.110 |
Why?
|
Language | 1 | 2022 | 1529 | 0.110 |
Why?
|
Adenoma | 1 | 2024 | 2147 | 0.110 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 759 | 0.110 |
Why?
|
Weight Loss | 1 | 2024 | 2671 | 0.100 |
Why?
|
Cell Count | 1 | 2016 | 1835 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 21990 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1584 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2024 | 10750 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 905 | 0.100 |
Why?
|
Sarcoidosis | 1 | 2017 | 520 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1795 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3068 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1632 | 0.090 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2011 | 144 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15782 | 0.090 |
Why?
|
Postoperative Period | 1 | 2016 | 1806 | 0.090 |
Why?
|
Electromyography | 1 | 2016 | 1388 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1263 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3167 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2547 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 39815 | 0.080 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1176 | 0.080 |
Why?
|
Weight Gain | 1 | 2019 | 2345 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2324 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2293 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4158 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7799 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15209 | 0.070 |
Why?
|
Internet | 1 | 2019 | 3081 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4808 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10478 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29493 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3732 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1276 | 0.070 |
Why?
|
Disease Progression | 1 | 2023 | 13464 | 0.070 |
Why?
|
Adolescent | 5 | 2021 | 87832 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8551 | 0.070 |
Why?
|
Regression Analysis | 3 | 2021 | 6336 | 0.060 |
Why?
|
Phenotype | 2 | 2021 | 16533 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6717 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2022 | 4403 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2495 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2467 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25931 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39018 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4313 | 0.060 |
Why?
|
Algorithms | 2 | 2023 | 13952 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4578 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6841 | 0.060 |
Why?
|
Radiosurgery | 1 | 2013 | 1341 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7226 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2012 | 2131 | 0.060 |
Why?
|
Blood Glucose | 1 | 2017 | 6349 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2024 | 414 | 0.050 |
Why?
|
Indium | 1 | 2022 | 46 | 0.050 |
Why?
|
Transducers, Pressure | 1 | 2022 | 51 | 0.050 |
Why?
|
Mass Screening | 1 | 2016 | 5413 | 0.050 |
Why?
|
Laryngeal Diseases | 1 | 2024 | 243 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15532 | 0.050 |
Why?
|
Liver | 1 | 2016 | 7503 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3524 | 0.040 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2019 | 86 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 829 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 437 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7366 | 0.040 |
Why?
|
New York | 1 | 2020 | 873 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 604 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20499 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2022 | 869 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21217 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1064 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15394 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 2017 | 600 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10135 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 917 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1569 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17275 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12076 | 0.030 |
Why?
|
Income | 1 | 2022 | 1867 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1371 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1563 | 0.030 |
Why?
|
Cadaver | 1 | 2016 | 1345 | 0.030 |
Why?
|
History, 20th Century | 1 | 2020 | 2770 | 0.030 |
Why?
|
Swine | 1 | 2022 | 5892 | 0.020 |
Why?
|
Animals | 2 | 2022 | 167777 | 0.020 |
Why?
|
Exhalation | 1 | 2012 | 181 | 0.020 |
Why?
|
Rare Diseases | 1 | 2017 | 618 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6069 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6758 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2536 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2355 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3440 | 0.020 |
Why?
|
Colon | 1 | 2017 | 1788 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1919 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4533 | 0.020 |
Why?
|
Length of Stay | 1 | 2022 | 6384 | 0.020 |
Why?
|
Crohn Disease | 1 | 2021 | 2275 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2017 | 2145 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5243 | 0.020 |
Why?
|
Depression | 1 | 2023 | 8052 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14478 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12950 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20039 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 12870 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11422 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36271 | 0.010 |
Why?
|
Child | 1 | 2012 | 79787 | 0.000 |
Why?
|